These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5536910)

  • 1. [Clinical experience with Anginin].
    Tokura K; Satake K
    Geka Chiryo; 1970 Oct; 23(4):471-2. PubMed ID: 5536910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of experimental and human athero- sclerosis by a bradykinin antagonist, pyridinol carbamate. (Preliminary report)].
    Shimamoto T; Numano F; Fujita T; Atsumi T
    Rev Atheroscler (Paris); 1967; 9(2):294-306. PubMed ID: 6064255
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical applications of anginin in ophthalmology. I. A case of the arteriosclerotic retinopathy with the retinal venous thrombosis favorably treated with anginin, especially effects of anginin on white sheating of the retinal artery.
    Matsuo N; Matsuo H; Hasegawa E; Obuchi Y
    Acta Med Okayama (1952); 1967 Apr; 21(2):59-66. PubMed ID: 4229454
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pyridinol-carbamate and atherosclerosis. Clinical studies and animal experiments].
    de Oliveira JM
    Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5303765
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pyridinolcarbamate in the therapy of hemicrania syndromes].
    Spina A
    Acta Neurol (Napoli); 1972; 27(6):610-7. PubMed ID: 4651488
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of pyridinolcarbamate on induced atherosclerosis in cynomolgus monkeys (Macaca ira).
    Malinow MR; McLaughlin P; Perley A
    Atherosclerosis; 1972; 15(1):31-6. PubMed ID: 4111120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].
    Heisig N; Westermann KW; Stolterfoht CA; Zaki J
    Med Klin; 1970 Dec; 65(52):2289-93. PubMed ID: 5522670
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyridinol-carbamate and atherosclerosis. Clinical observations and animal experimentation].
    de Oliveira JM
    Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5310119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyridinol carbamate in atherosclerosis].
    Sanwald R
    Dtsch Med Wochenschr; 1972 Apr; 97(14):583-4. PubMed ID: 5022146
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA; Fajardo JD; Velles Aguirre L; Quijano E; Ciliberti E; Lucarelli R
    Prensa Med Argent; 1970 Apr; 57(8):394-8. PubMed ID: 5517707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of pyridinolcarbamate in the treatment of diabetic angiopathies and atheromatous arteritis].
    Plauchu M; Bussy L; Rondelet J
    Lyon Med; 1972 Feb; 227(3):271-7. PubMed ID: 5037162
    [No Abstract]   [Full Text] [Related]  

  • 13. [New drugs registered in Austria].
    Wien Klin Wochenschr; 1972 Mar; 84(12):200-1. PubMed ID: 5012428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anginin in the treatment of coronary artery disease].
    Markiewicz M; Korolko A; Jaroszyński G
    Pol Tyg Lek; 1973 Jun; 28(23):871-3. PubMed ID: 4720261
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of pyridinol-carbamate in ophthalmologic therapeutics].
    Pouliquen Y; Guyot-Argenton C
    Nouv Presse Med; 1972 Jan; 1(3):199-200. PubMed ID: 5061538
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of anginin administration in chronic obstructive arterial diseases of the lower extremity, with special reference to the determination of therapeutic effect using the dye index curve].
    Kaneko Y; Fukuzumi H; Uemichi A; Harada S; Uehara N
    Geka Chiryo; 1970 Apr; 22(4):465-8. PubMed ID: 4915897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Collected therapeutic experience with a phlebodymanic agents. Results with Glyvenol in 652 cases].
    Rétornaz AM
    Praxis; 1968 Jul; 57(29):1036-9. PubMed ID: 5755475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Local use of Thrombotsion salve for the treatment of superficial phlebitis, varicose complex and other dermatoses].
    Kejda J
    Landarzt; 1968 Apr; 44(11):560-3. PubMed ID: 5727855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the sulfonic ester of adrenochrome semicarbazone in the therapy of phlebopathies and obliterating arteriosclerotic arteriopathies of the lower extremities].
    Seghezzi R; Pedroni G; Ercoli A
    Chir Ital; 1967; 19():Suppl 2:349+. PubMed ID: 5190607
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical test using the drug DRA-363 in the treatment of varicose diseases].
    Mickelberg A
    Hospital (Rio J); 1970 May; 77(5):1633-45. PubMed ID: 4989586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.